ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
7,819.10
0.78%
S&P ASX All Technology
3,330.90
0.60%
Brent Oil
67.075
0.00%
US Dollar vs AUD
1.56535
0.00%
Bitcoin
84,833.55
-0.10%
Pepperstone
Advertisement
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. NeuroSense Therapeutics Ltd (NRSN)

  7. NeuroSense Therapeutics Ltd (NRSN) News

NeuroSense Therapeutics Ltd

NeuroSense Therapeutics Ltd (NRSN)

NASDAQ
1.0333
0.0023
(0.22%)
Closed 18 April 6:00AM
Delayed by 15 minutes
1.0333
0.00
(0.00%)
After Hours: 9:55AM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

NRSN News

Official News Only

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
23 February 2024
NRSN (0.22%)

NRSN Discussion

View Posts
johnhancoque johnhancoque 3 hours ago
Better to remain silent and be thought a fool than to open one's mouth and remove all doubt! Alon Ben Noon could have said nothing at all and let the market speculate for the past 6 months, however he thought it prudent to advise the markets and tweet rocket emojis and do cryptic interviews telling the market big things are going to happen yet never materialize. A good C.E.O. would understand this concept and keep silent then one day take the market off guard with the element of surprise on his side. As said so plainly at the beginning of this paragraph all rings true. GL everyone
👍️0
johnhancoque johnhancoque 8 hours ago
A good C.E.O. would send a letter to shareholders with new anticipated date on the conclusion of partnership. Silence and constant fluff news is unacceptable imho
👍️0
johnhancoque johnhancoque 2 days ago
In the right hands prime c would be a gamechanger. I'm not so sure prime c is in the right hands. Seems like all we ever hear about is soon. At what point does a person realize Alon Ben Noon is full of it? A month? Maybe. 2 months? That's a stretch. 3 and 4 months is out of the question and 5 months is absolutely unacceptable. People here are missing something but the market obviously isn't because the market cap doesn't move off 20 million month after month with constant selling pressure. No trust here unfortunately
👍️0
runncoach runncoach 2 days ago
What the company does have is a drug candidate that is made up of 2 already approved fda drugs. I've made half a fortune off two similar companies in the past. That's why I'm still around. Whether or not it works out, nobody knows.
👍️0
johnhancoque johnhancoque 2 days ago
Alon ben noon is not a man of his word plain and simple. What sort of a partnership takes 5 months to work out the details?
👍️0
runncoach runncoach 3 days ago
Better hope
👍️0
johnhancoque johnhancoque 3 days ago
So they have the ability to sell $30 million worth to an offshore investor, they need money bad and yet they don't. What am I missing here? They must be close to that deal with significant upfront cash payment
👍️0
runncoach runncoach 1 week ago
There was a pumping report that came out right before it crashed a few weeks ago even though they should have been signing the deal. That told me all I needed to know. Lots of turmoil with the new administration and markets. Company isn't sitting on the cash to run the next trial. They better hope they sign something soon or my guess is there will be a reverse split. Jmho
👍️0
johnhancoque johnhancoque 1 week ago
Doesn't look like a partnership ever existed according to some on stocktwits. I am hopeful but this isn't look8ng very good imho
👍️0
runncoach runncoach 3 weeks ago
Wonder the status of the "binding" term sheet that was supposed to materialize into a partnership this quarter? Market doesn't seem happy
👍️0
runncoach runncoach 2 months ago
Volume firming up with price. Maybe we'll get partnership details to push this above 2 bucks while we await P3 launch this summer.
👍️0
runncoach runncoach 3 months ago
If the company has to do another bridge money raise until a partnership, the recent filings of the last money raise likely show the reason the price remains so low IMO. The "most favored nations" clause tends to cap the share prices. That's besides the millions of warrant shares. Hopefully a buck and change holds.
👍️0
runncoach runncoach 3 months ago
Folks should be careful. If they don't get things finalized we could be looking at a reverse split. Partnerships don't always work out. Regardless, no sales in 2025 but hopefully they launch the P3 this summer as they project.
👍️0
runncoach runncoach 3 months ago
I told folks to be careful and not listen to the pump. If they don't get things finalized we could be looking at a reverse split
👍️0
johnhancoque johnhancoque 3 months ago
Just gained nasdaq compliance and now threatening it. If anything, this is an emberassing complication for the ceo. Something needs to change here because the hedge funds are clearly in violation of manipulating the share price. The market cap is only 19 million. The ceo needs to up his game and get some positive pr happening or these guys will continue to manipulate the share price every day
👍️0
runncoach runncoach 4 months ago
Apparently you don't follow but all good. I wasn't the one pumping 7.50 or 12 bucks and similar or pretending management bought 1.25 shared without mentioning the additional 8 million warrant shares. I read the financials. Most don't. Going to be a trading stock for a couple years IMO. Not much to see in 2025 but happy for the company and hope for the patients which is the most important thing and today progress was certainly made.

Very happy to see they are getting a partnership and have an avenue to begin their P3 next summer. Reminds me of the partnership for Neuren Pharma years back for Rett Syndrome although they treat a variety of underserved indications as well. If the drug works we should know maybe 2027. Hopefully longs will see a pay day down the road. Maybe something pans out with Canada in 2026.
👍️0
johnhancoque johnhancoque 4 months ago
Um...when was it approved? Blockbuster status won't be known until it's selling around the world, which won't be hard now with Big Pharma backing them. Your understanding of bios is very limited. Widen your horizons and stop wasting your time here as what you post makes very little sense anyways
👍️0
runncoach runncoach 4 months ago
Must have not been blockbuster, eh?
👍️0
johnhancoque johnhancoque 4 months ago
https://finance.yahoo.com/news/neurosense-therapeutics-enters-binding-term-140000065.html
👍️0
johnhancoque johnhancoque 4 months ago
Nobody claims a multibillion dollar partnership. Read the headlines. They are in discussions with several multi- billion dollar companies for partnerships. Also, they could have done a large public offering to keep the lights on as they are nasdaq listed. Instead the ceo chose to do a private placement and buy 5 million worth. The partnerships are for funding the continued trials and I know alot about how things work with pharma as I've been trading bios 20 years. The data is impressive and worth Billions and as the market catches on expect significant rises in the share price
👍️0
runncoach runncoach 4 months ago
How much do you think a P3 cost? That's why so little leverage. Why didn't they already get a partnership they've talked about for 4 months? It's not easy when you don't have cash. It's not going to be a multi billion partnership that I've seen some posting about. Ceo kept them listed and gave a couple months breathing room. Congrats to him
👍️0
johnhancoque johnhancoque 4 months ago
Right. You believe he did it to keep the lights on when he could have done a public offering for alot more. Instead, he spent 5 million of his own money suggesting he has faith in a very large partnership. Your way of thinking is twisted. No need reply again
👍️0
runncoach runncoach 4 months ago
I'm suggesting he bought to keep the company's listing and float the company til they find funding since they can't fund a P3 trial. It's not a strong position to negotiate from. I don't think I'm saying anything controversial or that isn't common sense at this point. I expect them to find something and then there will be a very long wait
👍️0
johnhancoque johnhancoque 4 months ago
You're suggesting the ceo bought 5 million worth of stock this month well above market value because he may not succeed in finding a partner? That sounds ridiculous buddy. It's more likely he is very confident in finding a partnership or is in the final stages so he bought 5 million worth. Your understanding of how insiders buys shares is out to bloody lunch. Hardly anyone would spend 5 million on a single stock without a near sure bet let alone a ceo of a publicly traded company
👍️0
johnhancoque johnhancoque 4 months ago
A ceo who had no faith in a partnership sure as he'll wouldn't pony up 5 million bucks if there was nothing in the works. Don't miss the forest for the trees. He bought 5 million worth because a partnership is in the works.
Smh
👍️0
runncoach runncoach 4 months ago
Been here long before you. Ceo ponied up money to meet Nasdaq requirements. Stock got shorted down so the "raise" price would look better.

Doesn't take a genius to realize not having the cash to even make it to the start of launching a P3 next summer isn't negotiating from a position of strength. If they don't get a partnership there would have to be a very unfavorable money raise to launch the trial. Between a rock and a hard place as far as negotiating.

Let's hope they get a partnership on favorable terms and a nice spike before the stock pulls back with the markets realizing another 12+ months til Canadian news and much longer than that for US.
👍️0
johnhancoque johnhancoque 4 months ago
So now and ceo who buys 5 million worth of stock isn't a good sign, it's a bad sign of a pump? Where do you guys come from, really?
Even with good news you shorts twist things unrecognizable. Truly unbelievable
The ceo bought 5 million worth 30% above the then market price. They don't need cash they need a partnership which they will have no problem finding and are in discussions right now with several Big Pharmas. Drugs like this don't go unnoticed long with Big pharma sniffing around. Just sell and get lost because your comments are useless to the investing community
👍️0
runncoach runncoach 4 months ago
Was wondering about the pump.

Folks will soon learn you don't get billion dollar partnerships when the CEO is having to buy stock to keep the lights on I'm afraid. Give me 3 bucks and I'll sit this one out for a while.
👍️0
johnhancoque johnhancoque 4 months ago
$7.50 Cantor price target 🥱👀
👍️0
runncoach runncoach 4 months ago
Not immediately it won't, no. Not in a price sustainable way that is. I own shares but will sell any significant spikes and buy back lower to hold long term
👍️0
johnhancoque johnhancoque 4 months ago
You don't understand. A partnership with BP takes NRSN to the next level no looking back. Once a partnership is announced with a large upfront payment, there will be no looking back for this company, ever. It will be bought by BIg Pharma long before p3 results. Easy to manufacture and worldwide protection until 2044
👍️0
runncoach runncoach 4 months ago
The problem is there is a large number of warrant shares available that will keep a lid on the share price after any spikes. Company has low funds considering it has yet to begin their P3. Sales are 2-3 years away at the least. Details of any partnership will be very important concerning future potential money raises. Sell significant spikes is my advice because folks sitting on warrants likely will. JMHO
👍️0
johnhancoque johnhancoque 4 months ago
$9.25 price target. Partnership news looks imminent. Only 25 million market cap has 400% to run at a minimum here
👍️0
johnhancoque johnhancoque 4 months ago
CEO bought 5 million worth and no matter how you spin that it will always be a boon for the company and shareholders. Regardless of what you say, any ceo who puts up 5 million bucks and above market for that matter says everything about where the sp is headed nearterm and speaks volumes about the confidence he has in his company and the data. Simple as that!
👍️0
McMagyar McMagyar 4 months ago
Except
The value would have already rocketed well past $1.25.. with so few shares out.. and after the news hit, the company could have raised the same amount of money by issuing fewer shares, less dilution, shares more valuable.. now only one shareholder benefits from knowing the good news.. sure looks like a shareholder lawsuit to me.. greed sucks.. maybe the other shareholders will let it go.. maybe they won't..
You can't control what happens, but you can control with whom you do bizness..
Thx Barrister.. wise words
👍️0
johnhancoque johnhancoque 4 months ago
All that matters is he bought 5 million shares @ $1.25 and the share price is about to rocket hard. Analysts price targets north of $12.00
👍️0
McMagyar McMagyar 4 months ago
This smells a lot like stealing to me..
All the other shareholders got diluted.. while the sole stock buyer of issuance becomes kazillionairre.. sounds like an attorney would want to know what the shareholder who bought all this stock knew.. and why the offering wasn't made to other shareholders?
👍️0
johnhancoque johnhancoque 4 months ago
Insider trading doesn't mean insiders can't buy shares or participate in offerings. There are however windows they have to abide by and if a significant partnership is announced in January they are well within their time to buy shares
👍️0
johnhancoque johnhancoque 4 months ago
Insider trading doesn't mean insiders can't buy shares or participate in offerings. There are however windows they have to abide by and if a significant partnership is announced in January they are well within their time to buy shares
👍️0
runncoach runncoach 4 months ago
That would look quite a bit like inside trading if they did that the next couple months. Trust me I hope so but doesn't look good to me.
👍️0
johnhancoque johnhancoque 4 months ago
$25.00 with partnership and large upfront payment
👍️0
johnhancoque johnhancoque 4 months ago
Um....he sold himself the last offering because there is a multi Billion dollar partnership about to be signed
👍 1
McMagyar McMagyar 4 months ago
It was a money raise to one guy.. total bullshit. Thief
👍️0
runncoach runncoach 4 months ago
The issue to me is the stock was sold down the last 2 or 3 weeks on "no news" and then we get a low price money raise. Doesn't look good
👍️0
McMagyar McMagyar 4 months ago
Co issues 12,000,000 share rights to one guy right before good news hits?  What a legal Scally wag.. what's to stop him from issuing himself another 10,000,000?  Know them but their greed.
What a crock
👍️0
runncoach runncoach 4 months ago
Today's PR would certainly lead one to believe no partnership type of completion until next year at the earliest IMO
👍️0
runncoach runncoach 5 months ago
Just under 21 million
👍️0
BurgerKing82 BurgerKing82 5 months ago
What's OS now?
👍️0
runncoach runncoach 8 months ago
From this evening's 6K. No idea if it's BS or not.
NeuroSense Therapeutics Ltd. (the Company) hereby reports that it is currently in advanced discussions with several multi-billion-dollar pharmaceutical companies regarding a potential strategic partnership for the development and commercialization of its lead drug candidate, PrimeC, for the treatment of Amyotrophic Lateral Sclerosis (ALS).



These discussions, based on non-binding terms, indicate the potential for substantial financial benefits to NeuroSense, including upfront payments, milestone payments and royalty payments as part of an agreement. NeuroSense anticipates receiving terms from these discussions in Q4 2024; however, there can be no assurance that terms will be finalized with any of the pharmaceutical companies, the timing, what would be the final terms, if any, or that a definitive agreement will be reached.
👍️0
runncoach runncoach 8 months ago
Money raise with .75 warrants attached fyi. Now we know why the price has remained so low IMO
👍️0

Your Recent History

NASDAQ
NRSN
NeuroSense Therapeutics
NASDAQ
IOVFX
International Opportunis...
LSE
0DX2
Ccb Real Estate Fund Ads...
NASDAQ
KBWB
Invesco KBW Bank ETF Tru...
NASDAQ
TENX
Tenax Therapeutics
BIT
G
Generali
LSE
14MC
Midland Hrt 44
LSE
LEND
Sancus Lending
LSE
0DZO
Financiere Marjos
COIN
AXIUSD
Axioms
COIN
LYXEUSD
LUKSO
COIN
LAUSD
LAToken
Delayed Upgrade Clock
ADVFN Logo
Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads